Literature DB >> 8806534

Analysis of FeLV-FAIDS provirus burden and productive infection in lymphocyte subsets in vivo.

S L Quackenbush1, G A Dean, J I Mullins, E A Hoover.   

Abstract

To help elucidate the immunopathogenesis of feline leukemia virus (FeLV)-induced immunodeficiency we studied the tropism of viruses derived from the FeLV-FAIDS isolate for lymphocyte subpopulations in cats. FeLV-FAIDS is composed of a replication-competent virus typical of subgroup A FeLV (prototype, clone 61E) and a family of replication-defective but immunopathogenic variant viruses (prototype, clone 61C). We sorted CD4+, CD8+, and IgG+ lymphocytes to > or = 97% purity and analyzed viral load in each cell population via genome-specific semiquantitative PCR. Both the 61E and 61C viruses were tropic for CD4+ and CD8+ T cells as well as IgG+ B lymphocytes in blood and lymph node. High provirus burden were established for both virus genomes-ranging from 0.3 to > 2 copies/cell. To identify the fraction of circulating cells which expressed viral antigen in vivo, we developed a flow cytometric method to simultaneously label blood leukocytes for surface immunophenotype and intracytoplasmic FeLV CA (p27 Gag). These experiments established that 20 to 60% of CD4+, CD8+, and IgG+ lymphocytes and > 85% of monocytes and granulocytes expressed FeLV p27 intracellularly. Thus the in vivo target cells for FeLV-FAIDS infection are manifold and include CD4+ and CD8+ T cells, B cells, and myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806534     DOI: 10.1006/viro.1996.0449

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.

Authors:  A S Lauring; M M Anderson; J Overbaugh
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Feline leukemia virus immunity induced by whole inactivated virus vaccination.

Authors:  Andrea N Torres; Kevin P O'Halloran; Laurie J Larson; Ronald D Schultz; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2009-10-31       Impact factor: 2.046

3.  Novel Orthopoxvirus and Lethal Disease in Cat, Italy.

Authors:  Gianvito Lanave; Giulia Dowgier; Nicola Decaro; Francesco Albanese; Elisa Brogi; Antonio Parisi; Michele Losurdo; Antonio Lavazza; Vito Martella; Canio Buonavoglia; Gabriella Elia
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

4.  Canine parvovirus type 2c infection in a kitten associated with intracranial abscess and convulsions.

Authors:  Nicola Decaro; Costantina Desario; Francesca Amorisco; Michele Losurdo; Maria Loredana Colaianni; Maria Fiorella Greco; Canio Buonavoglia
Journal:  J Feline Med Surg       Date:  2011-01-03       Impact factor: 2.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.